Reduces copayments and coinsurance for asthma inhalers covered by certain health benefits plans.
This bill reduces the maximum out-of-pocket cost for prescription asthma inhalers under New Jersey-regulated health insurance plans. It limits copayments and coinsurance for a 30-day supply of asthma inhalers to $35, down from the current $50 limit. The policy applies to various health insurance plans including individual and group policies, health maintenance organizations, and state-regulated health benefits plans. It requires these plans to cover asthma inhalers without deductibles and with the new $35 cost-sharing cap. The bill directly affects New Jersey residents with asthma who rely on inhalers and use health insurance plans regulated by the state.
Bill status
in committee
1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
Governor
Introduced Mar 6, 2025
Last action Mar 6, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
1
Key actions
0
Committee
0
Mar 6, 2025
Introduced
Introduced in the Assembly, Referred to Assembly Financial Institutions and Insurance Committee
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Mike Venezia
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about A 5393
Scope: NJ
Hi! I can help you understand A 5393. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline